Search

Your search keyword '"Marino, N."' showing total 366 results

Search Constraints

Start Over You searched for: Author "Marino, N." Remove constraint Author: "Marino, N." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
366 results on '"Marino, N."'

Search Results

2. Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells

3. Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approach

4. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells

8. Training Simulators for Gastrointestinal Endoscopy: Current and Future Perspectives

9. Publisher Correction: Hierarchical organization of perylene bisimides and polyoxometalates for photo-assisted water oxidation (Nature Chemistry, (2019), 11, 2, (146-153), 10.1038/s41557-018-0172-y)

10. AB0716 FIBROMYALGIA SYNDROME SEVERITY ACCORDING TO AGE CATEGORIES: RESULTS FROM A NATIONAL REGISTER

11. Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015

12. In situ resistance, not immigration, supports invertebrate community resilience to drought intensification in a Neotropical ecosystem

15. Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015

17. Use of PET/CT to detect local and regional laryngeal cancer recurrence after surgery

20. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells

24. Exploratory analysis for the evaluation of estimated glomerular filtration rate, cholesterol and triglycerides after switching from tenofovir/emtricitabine plus atazanavir/ritonavir (ATV/r) to abacavir/lamivudine plus ATV/r in patients with preserved renal function

26. Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART

27. Functional traits and environmental conditions predict community isotopic niches and energy pathways across spatial scales

28. Confined photo-release of nitric oxide with simultaneous two-photon fluorescence tracking in a cellular system

29. Exploratory analysis for the evaluation of estimated glomerular filtration rate, cholesterol and triglycerides after switching from tenofovir/emtricitabine plus atazanavir/ritonavir (ATV/r) to abacavir/lamivudine plus ATV/r in patients with preserved renal function

30. Flow Cytometric Measurement of the Initial In Vivo Response to Prednisone Provides New Prognostic Information in Childhood Acute Lymphoblastic Leukemia (ALL)

31. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort

32. ANALISIS FINGERPRINT DAUN GEDI HIJAU (Abelmoschus manihot L) UNTUK MEMPREDIKSI AKTIVITAS ANTIOKSIDAN MENGGUNAKAN KOMBINASI SPEKTROSKOPI IR DENGAN PARTIAL LEAST SQUAREREGRESSION

33. Is remote live urologic surgery a reality? Evidences from a systematic review of the literature.

36. Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting

37. Severe Bone Marrow Suppression Associated with Use of Clopidogrel

39. Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy

40. IL RESTAURO DEL TEATRO COMUNALE 'Salvatore Cicero' Cronaca di un cantiere

42. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort

45. Overexpression of h-prune in breast cancer is correlated with advanced disease status

49. Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI

Catalog

Books, media, physical & digital resources